Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 679813, 9 pages
http://dx.doi.org/10.1155/2015/679813
Research Article

Autoimmune Hepatitis in Brazilian Children: IgE and Genetic Polymorphisms in Associated Genes

1Laboratório de Medicina Laboratorial (LIM03), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, 05403-000 São Paulo, SP, Brazil
2Hospital Israelita Albert Einstein, 05652-900 São Paulo, SP, Brazil
3Instituto de Investigação em Imunologia, Instituto Nacional de Ciência e Tecnologia, 05403-000 São Paulo, SP, Brazil
4Laboratório de Imunologia, Instituto do Coração (InCor), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, 05403-000 São Paulo, SP, Brazil
5Laboratório de Histocompatibilidade e Imunidade Celular (LIM19), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, 05403-000 São Paulo, SP, Brazil
6Departamento de Hepatologia, Instituto da Criança, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, 05403-000 São Paulo, SP, Brazil
7Divisão de Alergia e Imunologia Clínica, Faculdade de Medicina, Universidade de São Paulo, 05403-000 São Paulo, SP, Brazil

Received 18 June 2015; Accepted 12 October 2015

Academic Editor: Fulvia Ceccarelli

Copyright © 2015 Léa Campos de Oliveira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. L. Krawitt, “Autoimmune hepatitis,” The New England Journal of Medicine, vol. 354, no. 1, pp. 54–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. G. V. Gregorio, B. Portmann, F. Reid et al., “Autoimmune hepatitis in childhood: a 20-year experience,” Hepatology, vol. 25, no. 3, pp. 541–547, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Czaja, F. Cassani, M. Cataleta, P. Valentini, and F. B. Bianchi, “Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis,” Hepatology, vol. 24, no. 5, pp. 1068–1073, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. G. F. Bottazzo, A. Florin-Christensen, A. Fairfax, G. Swana, D. Doniach, and U. Groeschel-Stewart, “Classification of smooth muscle autoantibodies detected by immunofluorescence,” Journal of Clinical Pathology, vol. 29, no. 5, pp. 403–410, 1976. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Bridoux-Henno, G. Maggiore, C. Johanet et al., “Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody,” Clinical Gastroenterology and Hepatology, vol. 2, no. 9, pp. 825–830, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. P. L. Bittencourt, A. C. Goldberg, E. L. R. Cançado et al., “Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2,” American Journal of Gastroenterology, vol. 94, no. 7, pp. 1906–1913, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Porta, “Clinical and laboratory features of Brazilian children with autoimmune hepatitis types 1 and 2,” Journal of Pediatric Gastroenterology and Nutrition, vol. 31, supplement 2, pp. S4–S19, 2000. View at Google Scholar
  8. G. Porta, K. Rosa, I. K. Miura et al., “Autoimmune hepatitis type 1 in children is associated with high IgE levels,” Journal of Pediatric Gastroenterology and Nutrition, vol. 39, supplement 2, pp. S175–S176, 2004. View at Google Scholar
  9. E. Van Epps, G. Husby, R. C. Williams Jr., and R. G. Strickland, “Liver disease—a prominent cause of serum IgE elevation,” Clinical and Experimental Immunology, vol. 23, no. 3, pp. 444–450, 1976. View at Google Scholar · View at Scopus
  10. S. Ghosh, M. Bhattacharya, and S. Dhar, “Churg-strauss syndrome,” Indian Journal of Dermatology, vol. 56, no. 6, pp. 718–721, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Shimomura, Y. Takase, S. Matsumoto et al., “Primary sclerosing cholangitis associated with increased peripheral eosinophils and serum IgE,” Journal of Gastroenterology, vol. 31, no. 5, pp. 737–741, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Fairley, L. F. Chang, and G. J. Giudice, “Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid,” Journal of Investigative Dermatology, vol. 125, no. 3, pp. 467–472, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Hirano, M. Tada, H. Isayama et al., “Clinical analysis of high serum IgE in autoimmune pancreatitis,” World Journal of Gastroenterology, vol. 16, no. 41, pp. 5241–5246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Yabiku, M. Hayashi, I. Komiya et al., “Polymorphisms of interleukin (IL)-4 receptor alpha and signal transducer and activator of transcription-6 (Stat6) are associated with increased IL-4Ralpha-Stat6 signalling in lymphocytes and elevated serum IgE in patients with Graves' disease,” Clinical and Experimental Immunology, vol. 148, no. 3, pp. 425–431, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. J. M. Schuerwegh, A. Ioan-Facsinay, A. L. Dorjée et al., “Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 6, pp. 2586–2591, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. Atta, M. B. Santiago, F. G. Guerra, M. M. Pereira, and M. L. B. S. Atta, “Autoimmune response of IgE antibodies to cellular self-antigens in systemic lupus erythematosus,” International Archives of Allergy and Immunology, vol. 152, no. 4, pp. 401–406, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Punnonen, R. de Waal Malefyt, P. van Vlasselaer, J.-F. Gauchat, and J. E. de Vries, “IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes,” Journal of Immunology, vol. 151, no. 3, pp. 1280–1289, 1993. View at Google Scholar · View at Scopus
  18. R. M. Reiman, R. W. Thompson, C. G. Feng et al., “Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity,” Infection and Immunity, vol. 74, no. 3, pp. 1471–1479, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. G. Chiaramonte, D. D. Donaldson, A. W. Cheever, and T. A. Wynn, “An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response,” The Journal of Clinical Investigation, vol. 104, no. 6, pp. 777–785, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. T. A. Wynn, “IL-13 effector functions,” Annual Review of Immunology, vol. 21, pp. 425–456, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. J. Czaja and H. A. Carpenter, “Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis,” Hepatology, vol. 39, no. 6, pp. 1631–1638, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Mitsuyasu, Y. Yanagihara, X.-Q. Mao et al., “Cutting edge: dominant effect of Ile50Val variant of the human IL-4 receptor alpha-chain in IgE synthesis,” The Journal of Immunology, vol. 162, no. 3, pp. 1227–1231, 1999. View at Google Scholar · View at Scopus
  23. F. Alvarez, P. A. Berg, F. B. Bianchi et al., “International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis,” Journal of Hepatology, vol. 31, no. 5, pp. 929–938, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. M. B. De Biasio, N. Periolo, A. Avagnina et al., “Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis,” Journal of Clinical Pathology, vol. 59, no. 4, pp. 417–423, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. C. Cherñavsky, N. Paladino, A. E. Rubio et al., “Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children,” Human Immunology, vol. 65, no. 7, pp. 683–691, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Alvarez, P. A. Berg, F. B. Bianchi et al., “International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis,” Journal of Hepatology, vol. 31, no. 5, pp. 929–938, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. L. C. C. Gayotto, V. A. F. Alves, and E. Strauss, Doenças do Fígado e Vias Biliares, Atheneu, Sao Paulo, Brazil, 1st edition, 2001.
  28. C. E. Bacchi and A. M. Gown, “Detection of cell proliferation in tissue sections,” Brazilian Journal of Medical and Biological Research, vol. 26, no. 7, pp. 677–687, 1993. View at Google Scholar · View at Scopus
  29. J. D. Bignon and M. A. Fernandes-Viña, “Protocols of the12 th International Histocompatibility Workshop for typing of HLA class II alleles by DNA amplification by polymerase chain reaction (PCR) and hybridization with sequence specific oligonucleotide probes (SSOP),” in Genetic Diversity of HLA. Functional and Medical Implications, D. Charron, Ed., p. 584, EDK, Paris, France, 1997. View at Google Scholar
  30. N. Shibata, T. Ohnuma, T. Takahashi et al., “The effect of IL4 +33C/T polymorphism on risk of Japanese sporadic Alzheimer's disease,” Neuroscience Letters, vol. 323, no. 2, pp. 161–163, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Hiromatsu, T. Fukutani, M. Ichimura et al., “Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease,” The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 1, pp. 296–301, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Mitsuyasu, Y. Yanagihara, X.-Q. Mao et al., “Cutting edge: dominant effect of Ile50Val variant of the human IL-4 receptor α-chain in IgE synthesis,” The Journal of Immunology, vol. 162, no. 3, pp. 1227–1231, 1999. View at Google Scholar · View at Scopus
  33. K. Takatsu, “Interleukin 5 and B cell differentiation,” Cytokine and Growth Factor Reviews, vol. 9, no. 1, pp. 25–35, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. A. C. Goldberg, P. L. Bittencourt, B. Mougin et al., “Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus,” Human Immunology, vol. 62, no. 2, pp. 165–169, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Farahi, N. R. Singh, S. Heard et al., “Use of 111-Indium-labeled autologous eosinophils to establish the in vivo kinetics of human eosinophils in healthy subjects,” Blood, vol. 120, no. 19, pp. 4068–4071, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Ben-Ari Shpirer, J. D. Booth, S. D. Gupta, K. Rolles, A. P. Dhillon, and A. K. Burroughs, “Morphometric image analysis and eosinophil counts in human liver allografts,” Transplant International, vol. 8, no. 5, pp. 346–352, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Suzuki, E. M. Brunt, D. E. Kleiner et al., “The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury,” Hepatology, vol. 54, no. 3, pp. 931–939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Kargili, N. Bavbek, A. Kaya, A. Koşar, and Y. Karaaslan, “Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases,” Rheumatology International, vol. 24, no. 6, pp. 321–324, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. A. J. Lucendo, Á. Arias, L. C. De Rezende et al., “Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study,” Journal of Allergy and Clinical Immunology, vol. 128, no. 5, pp. 1037–1046, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. A. E. Kelly-Welch, E. M. Hanson, M. R. Boothby, and A. D. Keegan, “Interleukin-4 and interleukin-13 signaling connections maps,” Science, vol. 300, no. 5625, pp. 1527–1528, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. P. E. Graves, M. Kabesch, M. Halonen et al., “A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children,” Journal of Allergy and Clinical Immunology, vol. 105, no. 3, pp. 506–513, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. W. Chen, M. B. Ericksen, L. S. Levin, and G. K. K. Hershey, “Functional effect of the R110Q IL13 genetic variant alone and in combination with IL4RA genetic variants,” Journal of Allergy and Clinical Immunology, vol. 114, no. 3, pp. 553–560, 2004. View at Publisher · View at Google Scholar
  43. M. J. Basehore, T. D. Howard, L. A. Lange et al., “A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects,” The Journal of Allergy and Clinical Immunology, vol. 114, no. 1, pp. 80–87, 2004. View at Publisher · View at Google Scholar · View at Scopus